ELF made a statement in September 2021 about the purchase of the company Vectura, which produces inhalers, by Philip Morris International, a tobacco company. https://europeanlung.org/en/news-and-blog/elf-response-to-sale-of-vectura-to-philip-morris-international/.
Now a document has been developed by a number of organisations in the UK, including Asthma UK and British Lung Foundation (now Asthma and Lungs UK), to provide advice to people who want to know if their inhaler is affected and what to do if they want to change. https://www.blf.org.uk/sites/default/files/Patient%20information%20about%20inhaler%20links%20to%20the%20tobacco%20industry.pdf
In addition, the COPD Foundation in the US are carrying out a survey to gather the views of people using inhalers to find out their thoughts. Please find here the links to the survey:
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.